Apella is a health care technology startup founded in 2019 with a mission to revolutionize the field of surgery. Their slogan "Technology for better surgery" encapsulates their dedication to leveraging artificial intelligence, computer vision, and modern communications to enhance crucial healthcare processes.
In a significant milestone, Apella secured a $21.00M Series A investment on 20 December 2021, attracting a notable group of investors including Casdin Capital, Upside Partnership, Operator Partners, PFM Health Sciences, Vensana Capital, and Twine Ventures.
With their headquarters in the United States, Apella is well-positioned to drive innovation in the healthcare sector and meet the increasing demand for advanced surgical technologies.
Apella's ambitious vision, coupled with strong investor backing, signals promising potential for growth and impact within the healthcare industry.